No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic

Luisa Mirone, Angelo Zoli, Elisa Gremese, Elisa Gremese, Stefano Alivernini, Lucia Lanzo, Fabrizio Melpignano, Pietro Rubortone, Giacomo Tanti, Carlo Tur, Dario Bruno, Laura Gigante, Gerlando Natalello, Lucrezia Verardi, Clara Di Mario, Barbara Tolusso, Marco Maria Lizzio, Silvia Laura Bosello

Research output: Contribution to journalArticle

Abstract

NA
Original languageEnglish
Pages (from-to)2644-2646
Number of pages3
JournalRheumatology
Volume59
DOIs
Publication statusPublished - 2020

Keywords

  • Betacoronavirus
  • Biological Products
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Immunosuppressive Agents
  • Italy
  • Pandemics
  • Pneumonia, Viral
  • Receptors, Interleukin-6
  • Respiration Disorders
  • Rheumatic Diseases
  • Risk Factors
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic'. Together they form a unique fingerprint.

Cite this